SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: bill small who wrote (12)3/8/1996 5:43:00 AM
From: Asymmetric   of 258
 
Jones Medical has basically doubled in price over the last two months. It's price at present is $38/sh. It split 3 for 2 on March 1, and raised it's quarterly dividend to boot. In Jan. analyst coverage was initiated by Robertson Stephenson, Donald Ellis with a buy, propelling the stock upward +$3 a share to about $26 and change. They've carved a strong niche for themselves in the critical pharmaceutical market with lead product Thrombin showing the way to record earnings in 1995. This area comprises 45% of their revenues (and growing obviously), and is the area exciting most investors. They also make vitamins & nutritional supplements for the other 55%. You can find a writeup on them at researchmag.com. At their present pe of 43 I wouldn't touch it....it's too expensive for me. When they started their march up, they jumped so fast, and their pullbacks were so brief, that I didn't have much of a chance to get in on the cheap.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News